Palo Alto, Calif. — November 4, 2025 — Leads & Copy — BridgeBio Pharma, Inc. (Nasdaq: BBIO) will have members of its management team host fireside chats at the UBS Global Healthcare Conference in Palm Beach Gardens, FL, on Monday, November 10 at 1:15 pm EST, and at the Jefferies Global Healthcare Conference in London, UK, on Tuesday, November 18 at 11:00 am EST.
To access the live webcast of BridgeBio’s presentations, visit the “Events and Presentations” page within the Investors section of the BridgeBio website at https://investor.bridgebio.com. A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.
BridgeBio Pharma, Inc. (BridgeBio; Nasdaq: BBIO) is a biopharmaceutical company dedicated to discovering, creating, testing, and delivering transformative medicines to treat patients with genetic diseases. Founded in 2015, BridgeBio’s pipeline ranges from early science to advanced clinical trials.
BridgeBio Media Contact:
Bubba Murarka, Executive Vice President, Corporate Development
contact@bridgebio.com
(650)-789-8220
BridgeBio Investor Contact:
Chinmay Shukla, Senior Vice President, Strategic Finance
ir@bridgebio.com
Source: BridgeBio Pharma, Inc.
